$2.00
-0.05 (-2.68%)
Geron Corp (NASDAQ:GERN)
CAPS Rating:
A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.
RSS Headlines
Fool UK